T1	PROC 46 66	Estudio de fase I/Ib
T2	PROC 92 103	monoterapia
#1	AnnotatorNotes T2	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T3	CHEM 133 142	anti-PD-1
T4	DISO 161 176	tumores sólidos
#2	AnnotatorNotes T4	C0280100; Solid Neoplasm; Neoplastic Process
T5	DISO 189 197	linfomas
#3	AnnotatorNotes T5	C0024299; Lymphoma; Neoplastic Process
T6	PROC 220 285	Estudio de fase I/Ib abierto, multicéntrico, de escalada de dosis
T7	PROC 312 323	monoterapia
#4	AnnotatorNotes T7	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T8	CHEM 353 362	anti-PD-1
T9	DISO 381 396	tumores sólidos
#5	AnnotatorNotes T9	C0280100; Solid Neoplasm; Neoplastic Process
T10	DISO 409 417	linfomas
#6	AnnotatorNotes T10	C0024299; Lymphoma; Neoplastic Process
T11	DISO 441 456	Tumores sólidos
#7	AnnotatorNotes T11	C0280100; Solid Neoplasm; Neoplastic Process
T12	DISO 460 468	linfomas
#8	AnnotatorNotes T12	C0024299; Lymphoma; Neoplastic Process
T13	DISO 511 526	tumores sólidos
#9	AnnotatorNotes T13	C0280100; Solid Neoplasm; Neoplastic Process
T14	DISO 556 564	linfomas
#10	AnnotatorNotes T14	C0024299; Lymphoma; Neoplastic Process
T15	PROC 584 595	tratamiento
#11	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	PROC 614 621	cirugía
#12	AnnotatorNotes T16	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T17	DISO 682 694	metastásicos
#13	AnnotatorNotes T17	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T18	DISO 697 705	linfomas
#14	AnnotatorNotes T18	C0024299; Lymphoma; Neoplastic Process
T19	DISO 744 754	enfermedad
#15	AnnotatorNotes T19	C0012634; Disease; Disease or Syndrome
T20	PROC 770 777	biopsia
#16	AnnotatorNotes T20	C0005558; Biopsy; Diagnostic Procedure
T21	PROC 803 818	biopsia tumoral
T22	DISO 811 818	tumoral
#17	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T23	PROC 871 882	tratamiento
#18	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	PROC 947 964	biopsia del tumor
T25	DISO 1125 1185	metástasis en el Sistema nervioso central (SNC) sintomáticas
#19	AnnotatorNotes T25	C0686377; CNS metastases; Neoplastic Process
T26	ANAT 1142 1166	Sistema nervioso central
#20	AnnotatorNotes T26	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T27	ANAT 1168 1171	SNC
#21	AnnotatorNotes T27	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T28	DISO 1189 1209	metástasis en el SNC
#22	AnnotatorNotes T28	C0686377; CNS metastases; Neoplastic Process
T29	ANAT 1206 1209	SNC
#23	AnnotatorNotes T29	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T30	PROC 1223 1236	terapia local
T31	ANAT 1249 1252	SNC
#24	AnnotatorNotes T31	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T32	PROC 1259 1271	radioterapia
#25	AnnotatorNotes T32	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T33	PROC 1274 1281	cirugía
#26	AnnotatorNotes T33	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T34	PROC 1296 1310	diagnosticados
#27	AnnotatorNotes T34	C0011900; Diagnosis; Diagnostic Procedure
T35	DISO 1314 1335	linfomas de células T
#28	AnnotatorNotes T35	C0079772; T-Cell Lymphoma; Neoplastic Process
T36	PROC 1352 1374	trasplantes alogénicos
#29	AnnotatorNotes T36	C0040739; Transplantation, Homologous; Therapeutic or Preventive Procedure
T37	PROC 1421 1428	terapia
#30	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	DISO 1457 1488	reacciones de hipersensibilidad
#31	AnnotatorNotes T38	C0020517; Hypersensitivity; Pathologic Function
T39	DISO 1526 1538	intolerancia
#32	AnnotatorNotes T39	C0277585; Intolerance to drug; Pathologic Function
T40	PROC 1541 1554	inmunoterapia
#33	AnnotatorNotes T40	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T41	PROC 1673 1682	protocolo
#34	AnnotatorNotes T41	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T42	DISO 1603 1624	AA inmuno-relacionado
#35	AnnotatorNotes T42	C4087225; Immune-mediated adverse reaction; Pathologic Function
T43	PROC 1396 1404	tratados
#36	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	CHEM 1429 1438	anti-GITR
T45	CHEM 1504 1508	mAcs
#37	AnnotatorNotes T45	C3542957; Monoclonal antibodies, antineoplastic; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T46	DISO 654 669	tumores sólidos
#38	AnnotatorNotes T46	C0280100; Solid Neoplasm; Neoplastic Process
T47	DISO 959 964	tumor
#39	AnnotatorNotes T47	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T48	ANAT 1326 1335	células T
#40	AnnotatorNotes T48	C0039194; T-Lymphocyte; Cell
T49	PROC 1056 1065	protocolo
#41	AnnotatorNotes T49	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T50	CHEM 70 76	GWN323
#42	AnnotatorNotes T50	C4287757; Anti-GITR Monoclonal Antibody GWN 323; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T51	CHEM 78 87	anti-GITR
T52	CHEM 125 131	PDR001
#43	AnnotatorNotes T52	C4053607; PDR001; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T53	CHEM 290 296	GWN323
#44	AnnotatorNotes T53	C4287757; Anti-GITR Monoclonal Antibody GWN 323; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T54	CHEM 298 307	anti-GITR
T55	CHEM 345 351	PDR001
#45	AnnotatorNotes T55	C4053607; PDR001; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T56	Date 13 17	2015
T57	LIVB 147 156	pacientes
#46	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 367 376	pacientes
#47	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 497 506	Pacientes
#48	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Neg_cue 565 567	no
T62	Spec_cue 755 769	susceptible de
T63	LIVB 887 895	paciente
#49	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T66	LIVB 1286 1295	Pacientes
#50	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 1338 1347	Pacientes
#51	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1386 1395	Pacientes
#52	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	LIVB 1512 1521	Pacientes
#53	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T61	PROC 983 999	Estado funcional
#54	AnnotatorNotes T61	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T64	PROC 625 650	Documentación histológica
#55	AnnotatorNotes T64	C0344441; Histology Procedure; Laboratory Procedure (?)
A1	Assertion T20 Speculated
A3	Assertion T16 Negated
A2	Status T36 History_of
A4	Status T43 History_of
A5	Status T37 History_of
A6	Status T44 History_of
A7	Status T38 History_of
A8	Status T40 History_of
A9	Status T39 History_of
A10	Status T42 History_of
#56	AnnotatorNotes T30	C1517925; Local Therapy; Therapeutic or Preventive Procedure 
#57	AnnotatorNotes T8	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#58	AnnotatorNotes T3	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#59	AnnotatorNotes T54	C4289972; Anti-GITR Monoclonal Antibody; Pharmacologic Substance
#60	AnnotatorNotes T44	C4289972; Anti-GITR Monoclonal Antibody; Pharmacologic Substance
#61	AnnotatorNotes T51	C4289972; Anti-GITR Monoclonal Antibody; Pharmacologic Substance
R1	Negation Arg1:T60 Arg2:T16	
R2	Speculation Arg1:T62 Arg2:T20	
T65	CONC 1017 1039	criterios de inclusion
A11	Assertion T65 Speculated
#62	AnnotatorNotes T65	C1512693; Inclusion Criteria; Qualitative Concept
T70	Spec_cue 1070 1076	puedan
R3	Speculation Arg1:T70 Arg2:T65	
T71	Neg_cue 1563 1575	incapaces de
T72	CONC 1576 1585	continuar
A12	Assertion T72 Negated
R4	Negation Arg1:T71 Arg2:T72	
T73	Spec_cue 1687 1693	puedan
T74	CONC 1634 1656	criterios de exclusion
A13	Assertion T74 Speculated
#63	AnnotatorNotes T74	C1512693; Inclusion Criteria; Qualitative Concept
R6	Speculation Arg1:T73 Arg2:T74	
R7	Used_for Arg1:T51 Arg2:T2	
R8	Used_for Arg1:T50 Arg2:T2	
R9	Combined_with Arg1:T50 Arg2:T52	
R10	Combined_with Arg1:T50 Arg2:T3	
R11	Combined_with Arg1:T51 Arg2:T52	
R12	Combined_with Arg1:T51 Arg2:T3	
R13	Experiences Arg1:T57 Arg2:T50	
R14	Experiences Arg1:T57 Arg2:T51	
R15	Experiences Arg1:T57 Arg2:T4	
R16	Experiences Arg1:T57 Arg2:T5	
T75	Quantifier_or_Qualifier 177 186	avanzados
#64	AnnotatorNotes T75	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R17	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T75	
R18	Used_for Arg1:T54 Arg2:T7	
R19	Used_for Arg1:T53 Arg2:T7	
R20	Combined_with Arg1:T54 Arg2:T55	
R21	Combined_with Arg1:T53 Arg2:T8	
R22	Experiences Arg1:T58 Arg2:T53	
R23	Experiences Arg1:T58 Arg2:T54	
R24	Experiences Arg1:T58 Arg2:T55	
R25	Experiences Arg1:T58 Arg2:T8	
R26	Experiences Arg1:T58 Arg2:T9	
R27	Experiences Arg1:T58 Arg2:T10	
T76	Quantifier_or_Qualifier 397 406	avanzados
#65	AnnotatorNotes T76	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R28	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T76	
T77	Quantifier_or_Qualifier 527 536	avanzados
#66	AnnotatorNotes T77	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
T78	Quantifier_or_Qualifier 541 553	metastásicos
#67	AnnotatorNotes T78	C1522484; metastatic qualifier; Functional Concept
R29	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T77	
R30	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T78	
T79	Quantifier_or_Qualifier 670 679	avanzados
#68	AnnotatorNotes T79	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R31	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T79	
R32	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T17	
R33	Location_of Arg1:T27 Arg2:T25	
R34	Location_of Arg1:T26 Arg2:T25	
T80	Quantifier_or_Qualifier 596 604	curativo
#69	AnnotatorNotes T80	C1880198; Cure (remedy); Conceptual Entity (?)
R35	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T80	
R38	Experiences Arg1:T59 Arg2:T13	
R39	Experiences Arg1:T59 Arg2:T14	
R40	Experiences Arg1:T59 Arg2:T15	
R41	Experiences Arg1:T59 Arg2:T16	
R45	Experiences Arg1:T63 Arg2:T24	
T81	Observation 907 916	dispuesto
#70	AnnotatorNotes T81	C0600109; Willing; Finding
R46	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T81	
R47	Overlap Arg1:T81 Arg2:T24	
T82	PROC 971 980	selección
#71	AnnotatorNotes T82	C0242802; Patient Selection; Research Activity
R48	Overlap Arg1:T24 Arg2:T82	
T83	Result_or_Value 1005 1008	≤ 2
T84	CONC 1000 1004	ECOG
#72	AnnotatorNotes T84	C1520224; ECOG performance status; Intellectual Product
R49	Used_for Arg1:T84 Arg2:T61	
R50	Has_Result_or_Value Arg1:T84 Arg2:T83	
T85	Quantifier_or_Qualifier 1011 1016	Otros
#73	AnnotatorNotes T85	C0205394; Other; Qualitative Concept
A14	Assertion T85 Speculated
R51	Has_Quantifier_or_Qualifier Arg1:T65 Arg2:T85	
R52	Speculation Arg1:T70 Arg2:T85	
R53	Location_of Arg1:T29 Arg2:T28	
R54	Location_of Arg1:T31 Arg2:T30	
R55	Location_of Arg1:T31 Arg2:T32	
R56	Location_of Arg1:T31 Arg2:T33	
R57	Location_of Arg1:T48 Arg2:T35	
R58	Experiences Arg1:T66 Arg2:T35	
R59	Experiences Arg1:T67 Arg2:T36	
R60	Experiences Arg1:T68 Arg2:T43	
R61	Experiences Arg1:T68 Arg2:T37	
R62	Used_for Arg1:T44 Arg2:T37	
R63	Used_for Arg1:T44 Arg2:T43	
R64	Causes Arg1:T45 Arg2:T38	
R65	Causes Arg1:T40 Arg2:T39	
R66	Experiences Arg1:T69 Arg2:T39	
R67	Experiences Arg1:T69 Arg2:T40	
R68	Experiences Arg1:T69 Arg2:T42	
T86	Quantifier_or_Qualifier 1628 1633	Otros
A15	Assertion T86 Speculated
#74	AnnotatorNotes T86	C0205394; Other; Qualitative Concept
R69	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T86	
R70	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T86	
R36	Overlap Arg1:T47 Arg2:T82	
T87	Quantifier_or_Qualifier 1586 1593	recibir
A16	Assertion T87 Negated
R5	Negation Arg1:T71 Arg2:T87	
R37	Experiences Arg1:T63 Arg2:T47	
#75	AnnotatorNotes T72	C0549178; Continuous; Idea or Concept (?)
#76	AnnotatorNotes T87	C1514756; Receive; Qualitative Concept
A17	Experiencer T57 Patient
A18	Experiencer T58 Patient
A19	Experiencer T59 Patient
A20	Experiencer T63 Patient
A21	Experiencer T66 Patient
A22	Experiencer T67 Patient
A23	Experiencer T68 Patient
A24	Experiencer T69 Patient
A25	Status T21 Future
